NCT05804903 - Investigation of the NVT ALLEGRA Plus THV System in Patients With Severe Aortic Stenosis or Failed Surgical Aortic Bioprosthesis | Biotech Hunter

Enrollment

177

Participants

Timeline

Start Date

November 24, 2023

Primary Completion Date

March 1, 2025

Study Completion Date

December 31, 2029

Conditions

Transcatheter Aortic Valve Implantation

Interventions

DEVICE

(ALLEGRA Plus Transcatheter Heart Valve) TAVI in severe calcified aortic stenosis or in failed surgical aortic bioprosthesis

Implantation of the ALLEGRA Plus Transcatheter Heart Valve in severe calcified aortic stenosis or in failed surgical aortic bioprosthesis

Trial Locations (7)

RECRUITING

Herzzentrum - Luzerner Kantonsspital, Lucerne

NOT_YET_RECRUITING

Deutsches Herzzentrum Berlin, Berlin

RECRUITING

Reina Sofia Hospital, Córdoba

RECRUITING

Hospital La Paz, Madrid

RECRUITING

Oulu University Hospital, Oulu

RECRUITING

Klinika Kardiochirurgii, Gdansk

RECRUITING

III Katedra Kardiologii, Katowice

All Listed Sponsors

lead

NVT GmbH

INDUSTRY